BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21428877)

  • 1. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
    Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
    Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).
    Pérez B; Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipain inhibition as a promising antimalarial target.
    Marco M; Coterón JM
    Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
    González JEH; Salas-Sarduy E; Alvarez LH; Valiente PA; Arni RK; Pascutti PG
    Curr Med Chem; 2024; 31(16):2234-2263. PubMed ID: 37711130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
    Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
    Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
    Li X; Chen H; Jeong JJ; Chishti AH
    Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof.
    Wegscheid-Gerlach C; Gerber HD; Diederich WE
    Curr Top Med Chem; 2010; 10(3):346-67. PubMed ID: 20166950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-plasmodial hits identified by virtual screening of the ZINC database.
    Mugumbate G; Newton AS; Rosenthal PJ; Gut J; Moreira R; Chibale K; Guedes RC
    J Comput Aided Mol Des; 2013 Oct; 27(10):859-71. PubMed ID: 24158745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falcipain cysteine proteases of malaria parasites: An update.
    Rosenthal PJ
    Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.